基本情報
- CAS
14729-84-1- 標準SMILES
NCC(=O)[O-].NCC(=O)[O-].O=S(=O)([O-])[O-].[Fe+2].[H+].[H+]- InChIKey
YJYOLOWXCPIBSY-UHFFFAOYSA-L- 分子式
- C4H10FeN2O8S
- 平均分子量
- 302.04 g/mol
- 単同位体質量
- 301.950722
名称と識別子
- 優先名称
- Ferrous glycine sulfate
- IUPAC
- bis(2-aminoacetate);hydron;iron(2+);sulfate
名称と別名
EINECS 238-784-356PS9HY5XIKelferonFe-capRefChem:599145Ferrous glycine sulfateFERROUS GLYCINE SULFATE [WHO-DD]Ferrous glycine sulphateIron(ii) glycine sulfateIRON, BIS(GLYCINATO)-, SULFATE (1:1)14729-84-1UNII-56PS9HY5XI
名称をさらに表示
Iron(2+) sulphate, compound with glycine (1:2)Ferro sanol (TN)Ferrous sulfate glycineFerrate(2-), bis(glycinato-kappaO)[sulfato(2-)-kappaO,kappaO']-, dihydrogenD08016
データベース識別子
- CAS
14729-84-1- PubChem CID
- 167159
- ChEMBL
CHEMBL3707208- EC Number
- 238-784-3
物性
構造計算による物性
- 極性表面積
- 221 Ų
- 水素結合供与体数
- 4
- 水素結合受容体数
- 10
- 回転可能結合数
- 0
- 重原子数
- 16
- 形式電荷
- 0
- 複雑度
- 99.6
化学と産業
薬理情報
ATC Code
B - Blood and blood forming organs
QB - Blood and blood forming organs
PharmacodynamicsThe major activity of supplemental iron is in the prevention and treatment of iron deficiency anemia. Iron has putative immune-enhancing, anticarcinogenic and cognition-enhancing activities.
Mechanism of ActionIron is necessary for the production of hemoglobin. Iron-deficiency can lead to decreased production of hemoglobin and a microcytic, hypochromic anemia.
Absorption, Distribution and Excretion
The efficiency of absorption depends on the salt form, the amount administered, the dosing regimen and the size of iron stores. Subjects with normal iron stores absorb 10% to 35% of an iron dose. Those who are iron deficient may absorb up to 95% of an iron dose.
関連反応
0 件
現在のフィルター条件では反応記録がありません。
化合物ノート
読み込み中…